Biodegradable Stents for Primary Sclerosing Cholangitis
Part of Digestive system clinical trials.
This trial tests a new type of stent (a small tube placed in bile ducts) that dissolves on its own over time in patients with primary sclerosing cholangitis (PSC), a rare disease affecting the bile ducts. The goal is to widen narrowed ducts and reduce the need for repeated procedures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with primary sclerosing cholangitis (PSC) with a high-grade stricture (severely narrowed bile duct)
- You have not had a stent placed or balloon dilation in your bile ducts in the past 4 months
- You do not currently have a bacterial infection in your bile ducts (cholangitis)
- Your liver function is relatively preserved (not severe cirrhosis)
- You do not have signs of bile duct cancer (cholangiocarcinoma) or other active cancer
- You are able to provide informed consent and understand the trial
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a fecal microbiota transplant (a procedure that puts healthy bacteria from a donor's stool into your gut) can help people with primary sclerosing cholangitis (PSC), a liver disease. It aims to see if this treatment can slow the disease and improve liver health.
This trial tests a new treatment called LB-P8 for people with primary sclerosing cholangitis (PSC), a liver disease. It aims to see if LB-P8 is safe and can help slow the disease down. You may join if you meet certain health requirements.
This study is testing a new type of stent that eventually dissolves on its own. The stent is placed in a narrowed bile duct to open it up and let bile flow properly. This might help people with strictures caused by scarring, stones, past surgeries, or certain bile duct cancers.
This study looks at what drives primary sclerosing cholangitis (PSC) and how it affects the body, using a team approach and medical tests like scans and blood work. It may help researchers understand PSC better and could improve future treatment decisions.
This study is testing a special temporary stent that breaks down over time to help open a narrowed bile duct after a liver transplant. It may help avoid long-term plastic stents or additional surgery.
This Phase 2 trial studies a “detoxification” approach to improve liver and bile-duct function in people with primary sclerosing cholangitis (PSC). It may help lower abnormal bile flow markers and see whether the treatment is safe for your liver.
Hear when a new Primary Sclerosing Cholangitis (PSC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.